These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17630922)

  • 1. Harnessing telomerase in cancer therapeutics.
    Fakhoury J; Nimmo GA; Autexier C
    Anticancer Agents Med Chem; 2007 Jul; 7(4):475-83. PubMed ID: 17630922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase: a target for cancer therapeutics.
    Shay JW; Wright WE
    Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anticancer therapeutics targeting telomerase.
    Ruden M; Puri N
    Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of telomerase activation and cellular immortalization in human cancer.
    Newbold RF
    Mutagenesis; 2002 Nov; 17(6):539-50. PubMed ID: 12435851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
    Fu XH; Zhang JS; Zhang N; Zhang YD
    World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Telomeres and telomerase as targeted therapies in cancer treatment].
    Souiden Y; Bouraoui A; Chaieb K; Mahdouani K
    Bull Cancer; 2010 Sep; 97(9):1087-104. PubMed ID: 20663741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
    Salimi-Jeda A; Badrzadeh F; Esghaei M; Abdoli A
    Cancer Treat Res Commun; 2021; 27():100323. PubMed ID: 33530025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
    Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
    Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
    Lei LX; Chen ZD
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer.
    Song JS
    Biosci Biotechnol Biochem; 2004 Aug; 68(8):1634-9. PubMed ID: 15322345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent patents on anti-telomerase cancer therapy.
    Agrawal A; Dang S; Gabrani R
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):102-17. PubMed ID: 21854360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase-Targeted Cancer Immunotherapy.
    Mizukoshi E; Kaneko S
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
    Guilleret I; Benhattar J
    Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
    Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
    Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere and telomerase in oncology.
    Mu J; Wei LX
    Cell Res; 2002 Mar; 12(1):1-7. PubMed ID: 11942406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
    Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase and telomeres: from basic biology to cancer treatment.
    Helder MN; Wisman GB; van der Zee GJ
    Cancer Invest; 2002; 20(1):82-101. PubMed ID: 11855380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.